| Trial ID: | L6865 |
| Source ID: | NCT00328393
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Effect of Pioglitazone on Ambulatory Blood Pressure
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hypertension|Diabetes Mellitus Type 2
|
| Interventions: |
DRUG: Pioglitazone|DRUG: Placebo
|
| Outcome Measures: |
Primary: Median of systolic 24-hour ambulatory blood pressure, Change of 24-hour blood pressure after 8 weeks of treatment, 8 weeks | Secondary: Median of 24-hour diastolic ambulatory blood pressure, Change of 24-hour diastolic blood pressure after 8 weeks of treatment, 8 weeks
|
| Sponsor/Collaborators: |
Sponsor: University of Erlangen-Nürnberg Medical School
|
| Gender: |
MALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
2
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2007-03
|
| Completion Date: |
2011-01
|
| Results First Posted: |
|
| Last Update Posted: |
2012-07-10
|
| Locations: |
CRC Medical Department IV, Erlangen, 91054, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00328393
|
